*Fatma Rabia Urun1,2, Tobias Hohenauer1, Elaine KY Chung1, Bogumil Kaczkowski3, Hiroaki Taniguchi1,9, Chee Wei Tee1,10, Saori Akimoto1, Mihoko Takahashi4, Rehab Abdelhamid5, Ana Maria Suzuki5, Susumu Goyama6, Mineo Kurokawa6, Takashi Umehara4,11, Erik Arner7, Charles Plessy8, Piero Carninci4, Adrian W Moore1
(1. Laboratory for Neurodiversity, RIKEN Center for Brain Science, Wako-shi, Saitama, Japan, 2. Graduate School of Science and Engineering, Saitama University, Saitama, Japan, 3. Laboratory for Genome Information Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 4. Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Kanagawa, Japan, 5. Laboratory for Transcriptome Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 6. Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, 7. Laboratory for Applied Regulatory Genomics Network Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan, 8. Genomics and Regulatory Systems Unit, Okinawa Institute of Science and Technology Graduate University, Onna-son, Kunigami-gun, Okinawa, Japan, 9. Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzebiec, Poland, 10. School of Health Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia, 11. PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan)